NL-OMON47515招募中不适用
Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial - FAST Therapy Trial
Hospital for Sick Children0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* Diagnosis: Fetal AF without hydrops or SVT without hydrops or SVT with hydrops.
- •* Tachyarrhythmia significant enough to justify immediate transplacental pharmacological treatment.
- •Maternal conditions:
- •* Gestational age <36 0/7 weeks at time of enrolment.
- •* Untreated at time of enrolment.
- •* Singleton pregnancy.
- •* Healthy mother with normal pre-treatment cardiovascular findings.
- •* Mother capable to make her own health decisions and to understand and follow medical instruction.
排除标准
- •* Fetal AF with hydrops.
- •* Any maternal-fetal conditions associated with high odds of premature delivery and/or death.
- •Maternal conditions:
- •* Any relevant preexisting heart condition.
- •* Relevant preexisting obstructive airway disease including asthma.
- •* History of chronic substance abuse.
- •* Intake of QT-prolonging medication.
- •* Serum potassium level <3.3 mEq/L.
- •* Ionized serum calcium level of <1 mmol/l.
- •* Serum creatinine level >1.1mg/dl.
研究者
相似试验
进行中（未招募）
1 期
Fetal atrial Flutter & Supraventricular Tachycardia (FAST) Therapy TrialFetal atrial flutter without hydrops, supraventricular tachycardia without hydrops and supraventricular tachycardia with hydropsEUCTR2015-005743-14-GBSt Georges University Hospital NHS Foundation Trust600
已完成
3 期
Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trialfetal atrial flutter, fetal supraventricular tachycardia, fetal hydropsI48I47Atrial fibrillation and flutterParoxysmal tachycardiaDRKS00016915The Hospital for Sick Children105
已完成
不适用
Antenatal anti-arrhythmic treatment for fetal tachycarrhythmiasfetal tachycarrhythmia(supraventricular tachycadia, atrial flutter)JPRN-UMIN000004270ational cerebral and cardiovascular center of Japan50
Unknown
不适用
Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic StrokeCryptogenic StrokeAtrial FibrillationAtrial TachycardiaNCT02374359Corporacion Parc Tauli210
已完成
不适用
A randomised controlled trial comparing the effect of ADmission Cardiotocography versus intermittent Auscultation of the foetal heart Rate on low-risk women on admission to labour ward showing signs of possible labourIntrapartum asphyxiaPregnancy and ChildbirthISRCTN96340041Health Research Board (HRB) (Ireland)5,776